Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0.500. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.500
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →the Council of Scientific and Industrial Research (CSIR), Government of India
Grant: Senior Research Fellowship
department of science and technology, ministry of science and technology
Grant: DST/INSPIRE/04/2014/002069
department of science and technology, ministry of science and technology
Grant: DST/INSPIRE/04/2014/002012
Department of Biotechnology, Ministry of Science and Technology
Grant: BT/PR6312/MED/29/605/2012
NIH HHS
Grant: P51 OD011133
FWCI
1.25
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals